Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
175.07
-8.09 (-4.42%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $7.05 billion as of September 10, 2026. Its market cap has increased by 226.94% in one year.
Market Cap
7.05B
Enterprise Value
6.56B
1-Year Change
226.94%
Ranking
Category
Stock Price
$175.07
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $7.05B, an increase of 4,776.77%. That is a compound annual growth rate of 143.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 7.05B | 17.49% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ionis Pharmaceuticals | 9.42B |
| Vaxcyte | 8.98B |
| ImmunityBio | 8.79B |
| Immunovant | 8.17B |
| Spyre Therapeutics | 8.01B |
| TG Therapeutics | 7.91B |
| Caris Life Sciences | 7.01B |
| Rhythm Pharmaceuticals | 7.01B |